Heparin for the treatment of lupus.

摘要

According to the invention there is provided a pharmaceutical composition which inhibits nephritis resulting from human systemic lupus erythematosis (SLE). Such kidney involvement is substantially decreased by administering a dosage of heparin, derivative or biologically effective fragment thereof which is adequate for the desired effect yet which is smaller than a dosage resulting in an appreciable anticoagulant effect.